LLY

761.09

+1.72%↑

JNJ

176.74

-0.37%↓

ABBV

216.34

+0.63%↑

UNH

340.87

-2.07%↓

AZN

77.37

-0.24%↓

LLY

761.09

+1.72%↑

JNJ

176.74

-0.37%↓

ABBV

216.34

+0.63%↑

UNH

340.87

-2.07%↓

AZN

77.37

-0.24%↓

LLY

761.09

+1.72%↑

JNJ

176.74

-0.37%↓

ABBV

216.34

+0.63%↑

UNH

340.87

-2.07%↓

AZN

77.37

-0.24%↓

LLY

761.09

+1.72%↑

JNJ

176.74

-0.37%↓

ABBV

216.34

+0.63%↑

UNH

340.87

-2.07%↓

AZN

77.37

-0.24%↓

LLY

761.09

+1.72%↑

JNJ

176.74

-0.37%↓

ABBV

216.34

+0.63%↑

UNH

340.87

-2.07%↓

AZN

77.37

-0.24%↓

Search

Clearside Biomedical Inc

Aperta

3.68 -3.41

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

3.61

Massimo

3.97

Metriche Chiave

By Trading Economics

Entrata

3.7M

-4.5M

Vendite

-1.8M

492K

Margine di Profitto

-913.618

Dipendenti

32

EBITDA

1.2M

-3.6M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+681.25% upside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-5.9M

26M

Apertura precedente

7.09

Chiusura precedente

3.68

Punteggio Tecnico

By Trading Central

Fiducia

Neutral Evidence

Clearside Biomedical Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

15 set 2025, 22:39 UTC

Acquisizioni, Fusioni, Takeovers

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15 set 2025, 16:43 UTC

I principali Market Mover

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15 set 2025, 16:42 UTC

I principali Market Mover

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15 set 2025, 16:35 UTC

I principali Market Mover

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15 set 2025, 23:46 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

15 set 2025, 23:46 UTC

Discorsi di Mercato

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15 set 2025, 23:34 UTC

Discorsi di Mercato

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15 set 2025, 22:48 UTC

Discorsi di Mercato

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15 set 2025, 22:12 UTC

Acquisizioni, Fusioni, Takeovers

CSL Expects Commercial Launch in 2029

15 set 2025, 22:12 UTC

Acquisizioni, Fusioni, Takeovers

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15 set 2025, 22:11 UTC

Acquisizioni, Fusioni, Takeovers

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15 set 2025, 22:11 UTC

Acquisizioni, Fusioni, Takeovers

CSL to Have Right to Exercise Option Based on Phase 3 Data

15 set 2025, 22:10 UTC

Acquisizioni, Fusioni, Takeovers

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15 set 2025, 21:16 UTC

Acquisizioni, Fusioni, Takeovers

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15 set 2025, 21:16 UTC

Acquisizioni, Fusioni, Takeovers

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15 set 2025, 21:15 UTC

Acquisizioni, Fusioni, Takeovers

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15 set 2025, 21:14 UTC

Acquisizioni, Fusioni, Takeovers

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15 set 2025, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

15 set 2025, 20:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

15 set 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

15 set 2025, 19:29 UTC

Discorsi di Mercato

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15 set 2025, 19:14 UTC

Discorsi di Mercato

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15 set 2025, 18:16 UTC

Discorsi di Mercato

Gold Powers to New High -- Market Talk

15 set 2025, 18:05 UTC

Discorsi di Mercato

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15 set 2025, 17:50 UTC

Acquisizioni, Fusioni, Takeovers

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15 set 2025, 17:10 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

15 set 2025, 17:10 UTC

Discorsi di Mercato

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15 set 2025, 16:52 UTC

Discorsi di Mercato

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15 set 2025, 16:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

15 set 2025, 16:20 UTC

Discorsi di Mercato
Utili

Auto & Transport Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Clearside Biomedical Inc Previsione

Obiettivo di Prezzo

By TipRanks

681.25% in crescita

Previsioni per 12 mesi

Media 2.5 USD  681.25%

Alto 3 USD

Basso 2 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Clearside Biomedical Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

6 ratings

0

Acquista

6

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

0.8417 / 0.8939Supporto e resistenza

A breve termine

Neutral Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Weak Bearish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Clearside Biomedical Inc

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
help-icon Live chat